Literature DB >> 21084614

Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences.

David E Moorman1, Gary Aston-Jones.   

Abstract

Recent studies show that glutamate and orexin (ORX, also known as hypocretin) inputs to the ventral tegmental area (VTA) dopamine (DA) cell region are essential for conditioned behavioral responses to reward-associated stimuli. In vitro experiments showed that ORX inputs to VTA potentiate responses of DA neurons to glutamate inputs, but it has remained unclear which glutamate inputs are modulated by ORX. The medial prefrontal cortex (mPFC) is a good candidate, given its role in processing complex stimulus-response information and its reciprocal connections with VTA DA neurons. Here we used in vivo recordings in anesthetized rats to investigate the responses of VTA DA neurons to mPFC stimulation, and how these responses are modulated by ORX. We demonstrate that mPFC stimulation evokes short- and long-latency excitation and inhibition in DA neurons. Maximal short-latency excitatory responses originated from stimulation sites in ventral prelimbic/infralimbic cortex, and were significantly more frequent during the active than during the rest period of the diurnal cycle. Application of ORX onto VTA DA neurons increased baseline activity and augmented or revealed excitatory responses to mPFC stimulation independent of changes in baseline activity, and without consistently affecting inhibitory responses. Moreover, orexin-1 receptor antagonism decreased tonic DA cell activity in active- but not rest-period animals, confirming a diurnal influence of ORX. These results indicate that ORX potently influences DA neuron activity, in part by modulating responses to mPFC inputs. By regulating prefrontal control of DA release, ORX projections to VTA may shape motivated behaviors in response to conditioned stimuli.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084614      PMCID: PMC3004096          DOI: 10.1523/JNEUROSCI.2871-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

Review 1.  The hypocretins: setting the arousal threshold.

Authors:  J Gregor Sutcliffe; Luis de Lecea
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

2.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

3.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.

Authors:  Y Yoshida; N Fujiki; T Nakajima; B Ripley; H Matsumura; H Yoneda; E Mignot; S Nishino
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

5.  Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area.

Authors:  J Fadel; A Y Deutch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area.

Authors:  S Jones; J A Kauer
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons.

Authors:  C A Paladini; C D Fiorillo; H Morikawa; J T Williams
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

8.  Fos expression in orexin neurons varies with behavioral state.

Authors:  I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

9.  Effects of cocaine administration on VTA cell activity in response to prefrontal cortex stimulation.

Authors:  L J Almodóvar-Fabregas; O Segarra; N Colón; J G Dones; M Mercado; C A Mejías-Aponte; R Vázquez; R Abreu; E Vázquez; J T Williams; C A Jiménez-Rivera
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons.

Authors:  François Georges; Gary Aston-Jones
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more
  52 in total

1.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 2.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

3.  Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.

Authors:  Zachary D Brodnik; David L Bernstein; Courtney D Prince; Rodrigo A España
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

Review 4.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 5.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling.

Authors:  K A Levy; Z D Brodnik; J K Shaw; D A Perrey; Y Zhang; R A España
Journal:  Psychopharmacology (Berl)       Date:  2017-06-30       Impact factor: 4.530

Review 7.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

8.  Role of lateral hypothalamus in two aspects of attention in associative learning.

Authors:  Daniel S Wheeler; Sandy Wan; Alexandra Miller; Nicole Angeli; Bayan Adileh; Weidong Hu; Peter C Holland
Journal:  Eur J Neurosci       Date:  2014-04-21       Impact factor: 3.386

9.  Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.

Authors:  Jessica K Shaw; Mark J Ferris; Jason L Locke; Zachary D Brodnik; Sara R Jones; Rodrigo A España
Journal:  Addict Biol       Date:  2016-08-02       Impact factor: 4.280

Review 10.  Neurobiological studies of fatigue.

Authors:  Mary E Harrington
Journal:  Prog Neurobiol       Date:  2012-07-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.